A Q2 Deep Dive: Product Momentum, China Recovery, and Operating Leverage Drive Results

Life sciences tools company Agilent Technologies (NYSE:A) announced better-than-expected revenue in Q2 CY2026, with sales up 8.1% year on year to $1.88 billion. Guidance for next quarter’s revenue was better than expected at $1.99 billion at the midpoint, 1% above analysts’ estimates. Its non-GAAP profit of $1.62 per share was 9% above analysts’ consensus estimates.